Us Bancorp \De\ Vericel Corp Transaction History
Us Bancorp \De\
- $75.6 Billion
- Q4 2024
A detailed history of Us Bancorp \De\ transactions in Vericel Corp stock. As of the latest transaction made, Us Bancorp \De\ holds 2,365 shares of VCEL stock, worth $138,707. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,365
Previous 3,069
22.94%
Holding current value
$138,707
Previous $129,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
20 transactions
Others Institutions Holding VCEL
# of Institutions
288Shares Held
49.7MCall Options Held
91.8KPut Options Held
23.2K-
Black Rock Inc. New York, NY8.06MShares$473 Million0.01% of portfolio
-
Brown Capital Management LLC Baltimore, MD3.83MShares$224 Million3.54% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.48MShares$204 Million0.0% of portfolio
-
State Street Corp Boston, MA2.43MShares$142 Million0.0% of portfolio
-
Invesco Ltd. Atlanta, GA2.37MShares$139 Million0.02% of portfolio
About Vericel Corp
- Ticker VCEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 47,178,000
- Market Cap $2.77B
- Description
- Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...